Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Alpha lactalbumin oleic acid - Hamlet Pharma

Next Previous
Drug Profile

Alpha lactalbumin oleic acid - Hamlet Pharma

Alternative Names: Alpha 1H; HAMLET; Human alpha-lactalbumin made lethal to tumours

Latest Information Update: 01 Jul 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hamlet Pharma AB
  • Developer Hamlet Pharma AB; Neurochase
  • Class Antineoplastics
  • Mechanism of Action Apoptosis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II/III Bladder cancer
  • Preclinical Brain cancer
  • No development reported Cancer; Colorectal cancer; Glioblastoma; Papilloma; Skin cancer

Most Recent Events

  • 25 Jun 2025 Hamlet Pharma plans a phase-III trial for Bladder cancer (Intravesicular),
  • 29 Jan 2024 Adverse events and efficacy data from a phase I/II trial in Bladder cancer released by Hamlet Pharma
  • 30 Nov 2023 Alpha lactalbumin oleic acid receives fast track status for Bladder cancer in USA

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top